Autobiography of Editorial Board Members
Copyright ©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Radiol. Apr 28, 2011; 3(4): 120-124
Published online Apr 28, 2011. doi: 10.4329/wjr.v3.i4.120
Feng Chen’s work on translational and clinical imaging
Feng Chen
Feng Chen, Section of Radiology, Department of Medical Diagnostic Sciences, Faculty of Medicine, University of Leuven, 3000 Leuven, Belgium
Feng Chen, Molecular Small Animal Imaging Center, University of Leuven, 3000 Leuven, Belgium
Feng Chen, Department of Radiology, Zhong Da Hospital, Southeast University, Nanjing 210009, Jiangsu Province, China
Author contributions: Chen F solely contributed to this manuscript.
Supported by Health Bureau of Jiangsu Province, China; Chinese Scholarship Council; National Natural Science Foundation of China; European Congress of Radiology 2000, EAR-ECR Research and Education Fund Fellowship Grant; European Union Asia-Link Project
Correspondence to: Feng Chen, MD, PhD, Section of Radiology, Department of Medical Diagnostic Sciences, Faculty of Medicine, University of Leuven, Herestraat 49, bus 7003, 3000 Leuven, Belgium.
Telephone: +32-16-330165 Fax: +32-16-343765
Received: October 11, 2010
Revised: March 28, 2011
Accepted: April 4, 2011
Published online: April 28, 2011

Dr. Feng Chen is a chief medical doctor and the vice chairman of the Department of Radiology in Zhong Da Hospital at Southeast University, Nanjing, China and a senior researcher in the Department of Radiology at the Catholic University of Leuven, Belgium. His main areas of interest are translational imaging research including stroke, tumor angiogenesis, assessment of therapeutic response in solid tumors, and magnetic resonance contrast media. Dr. Feng Chen has published 44 scientific papers in peer-reviewed international journals. He and his colleagues have developed an imaging platform which includes animal models, animal preparations and multiparametric magnetic resonance imaging (MRI) protocols for translational animal imaging research using clinical machines. His MRI findings on rodent stroke are considered to “serve as a model for future laboratory investigations of treatment of acute stroke and unify the approaches developed for clinical studies”. He and his colleagues have introduced a novel liver tumor model in rodents, in which a series of studies concerning the antitumor activity of vascular disrupting agents have been successively conducted and assessed by in vivo MRI, especially by diffusion weighted imaging as an imaging biomarker. His goal is to provide valuable references for clinical practice and to contribute to the translation of animal imaging research into patient applications.

Keywords: Animal study, Contrast agent, Magnetic resonance imaging, Therapeutic assessment, Translational research, Tumor angiogenesis, Tumor therapy, Vascular disrupting agent